The new clinical practice guideline, developed in tandem by representatives from 10 medical societies, provides evidence-based and consensus recommendations for safe benzodiazepine tapering when risks outweigh benefits.
Bronchodilator responsiveness appears to be a risk factor for incident chronic airflow obstruction, researchers stated after a 9-year multinational study.